See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Metamucil Treatment Report
See also: Metamucil Wafers
What is Metamucil? Metamucil® is a brand name for psyllium, an antidiarrheal laxative. It is used as a dietary fiber supplement; for the treatment of occasional constipation; and to reduce risk of coronary heart disease. Off label it is used for irritable bowel syndrome and inflammatory bowel disease.
See more information, including instructions, precautions, side effects, and interactions.
Reasons taken
43 patients in the community are taking or have taken Metamucil.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Constipation | 14 | 32% |
| Bowel problems | 10 | 23% |
| General health | 8 | 18% |
| Irritable Bowel Syndrome (IBS) | 2 | 4% |
| fiber supplement | 1 | 2% |
| Diarrhea | 1 | 2% |
| Other | 1 | 2% |
| Slow my MS progress | 1 | 2% |
| Support another treatment | 1 | 2% |
| 1tps. as needed | 3.4g/5.2g as needed | 5 500mg as needed | daily | 1 tps. daily | 2 mg daily | 2 tbs. daily | 2 tps. daily | 3 tps. daily | 3.4 g/11 g daily | 3.4 g/5.2 g daily | 3.4 g/7 g daily | 3.4 g daily | 5 tps. daily | 10 other daily | 500 mg daily | 1000 mg daily | 1500 mg daily | 2500 mg daily | 3000 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
3
|
2
|
5
|
2
|
4
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
||
Duration
How long current patients have been taking Metamucil or how long patients were taking Metamucil before stopping.
Currently Taking Metamucil
Stopped Taking Metamucil
Patient Reported Evaluations
Results from 3 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Can't tell | 100% | 1 |
|---|
General health
Side-effects (as an overall problem)
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 33% | 1 |
| None | 67% | 2 |
Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (1 of 3)
-
- expastrychef
- Sex: M
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: none
- Speech: none
- Swallowing: mild
- Upper limb: moderate
- Walking: moderate
- See profile
-
by expastrychef
Mar 14, 2009
- EfficacyModerate
- Side-effectsNone
- Bowel problems
- See full evaluation
-
0 helpful marks
Report created on November 08, 2009.